1-19 of 19
Roy Taylor
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission

Naveed Sattar, Shahrad Taheri, David P. Astling, Jessica Chadwick, Michael A. Hinterberg, Michael V. Holmes, Emma V. Troth, Paul Welsh, Hadeel Zaghloul, Odette Chagoury, Mike Lean, Roy Taylor, Steve Williams
Journal: Diabetes Care
Diabetes Care 2023;46(11):1949–1957
https://doi.org/10.2337/dc23-0602
Published: 26 September 2023
View article titled, Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission
Open the PDF for Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission in another window
Journal Articles

Philip Home—Insulin, Insight, and Internationalism

Roy Taylor
Journal: Diabetes Care
Diabetes Care 2022;45(3):497–501
https://doi.org/10.2337/dci21-0068
Published: 04 March 2022
View article titled, Philip Home—Insulin, Insight, and Internationalism
Open the PDF for Philip Home—Insulin, Insight, and Internationalism in another window
Journal Articles

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes

Matthew C. Riddle, William T. Cefalu, Philip H. Evans, Hertzel C. Gerstein, Michael A. Nauck, William K. Oh, Amy E. Rothberg, Carel W. le Roux, Francesco Rubino, Philip Schauer, Roy Taylor, Douglas Twenefour
Journal: Diabetes Care
Diabetes Care 2021;44(10):2438–2444
https://doi.org/10.2337/dci21-0034
Published: 30 August 2021
View article titled, Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
Open the PDF for Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes in another window
Journal Articles

Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes

Sviatlana V. Zhyzhneuskaya, Ahmad Al-Mrabeh, Carl Peters, Alison Barnes, Benjamin Aribisala, Kieren G. Hollingsworth, Alex McConnachie, Naveed Sattar, Michael E.J. Lean, Roy Taylor
Journal: Diabetes Care
Diabetes Care 2020;43(4):813–820
https://doi.org/10.2337/dc19-0371
Published: 14 February 2020
View article titled, Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes
Open the PDF for Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Erratum. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016;39: 808–815

Sarah Steven, Kieren G. Hollingsworth, Ahmad Al-Mrabeh, Leah Avery, Benjamin Aribisala, Muriel Caslake, Roy Taylor
Journal: Diabetes Care
Diabetes Care 2018;41(6):1321
https://doi.org/10.2337/dc18-er06
Published: 24 April 2018
View article titled, Erratum. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016;39: 808–815
Open the PDF for Erratum. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016;39: 808–815 in another window
Journal Articles

Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction

Michael G. White, James A.M. Shaw, Roy Taylor
Journal: Diabetes Care
Diabetes Care 2016;39(11):2080–2088
https://doi.org/10.2337/dc16-0619
Published: 11 October 2016
View article titled, Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction
Open the PDF for Type 2 Diabetes: The Pathologic Basis of Reversible β-Cell Dysfunction in another window
Journal Articles

Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders

Sarah Steven, Kieren G. Hollingsworth, Ahmad Al-Mrabeh, Leah Avery, Benjamin Aribisala, Muriel Caslake, Roy Taylor
Journal: Diabetes Care
Diabetes Care 2016;39(5):808–815
https://doi.org/10.2337/dc15-1942
Published: 21 March 2016
View article titled, Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders
Open the PDF for Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders in another window
Journal Articles

Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes

Sarah Steven, Kieren G. Hollingsworth, Peter K. Small, Sean A. Woodcock, Andrea Pucci, Benjamin Aribisala, Ahmad Al-Mrabeh, Ann K. Daly, Rachel L. Batterham, Roy Taylor
Journal: Diabetes Care
Diabetes Care 2016;39(1):158–165
https://doi.org/10.2337/dc15-0750
Published: 01 December 2015
View article titled, Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes
Open the PDF for Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Mechanism of Metabolic Advantages After Bariatric Surgery: It’s all gastrointestinal factors versus it’s all food restriction

Filip K. Knop, MD, Roy Taylor, MD
Journal: Diabetes Care
Diabetes Care 2013;36(Supplement_2):S287–S291
https://doi.org/10.2337/dcS13-2032
Published: 17 July 2013
View article titled, Mechanism of Metabolic Advantages After Bariatric Surgery: <subtitle>It’s all gastrointestinal factors versus it’s all food restriction</subtitle>
Open the PDF for Mechanism of Metabolic Advantages After Bariatric Surgery: <subtitle>It’s all gastrointestinal factors versus it’s all food restriction</subtitle> in another window
Journal Articles

Type 2 Diabetes: Etiology and reversibility

Roy Taylor, MD, FRCP
Journal: Diabetes Care
Diabetes Care 2013;36(4):1047–1055
https://doi.org/10.2337/dc12-1805
Published: 14 March 2013
View article titled, Type 2 Diabetes: <subtitle>Etiology and reversibility</subtitle>
Open the PDF for Type 2 Diabetes: <subtitle>Etiology and reversibility</subtitle> in another window
Journal Articles

Response to Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554

Roy Taylor, MD, Mei Jun Chen, BSC
Journal: Diabetes Care
Diabetes Care 2011;34(5):e56
https://doi.org/10.2337/dc11-0397
Published: 20 April 2011
View article titled, Response to Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554
Open the PDF for Response to Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554 in another window
Journal Articles

Response to Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554

Roy Taylor, MD, Mei Jun Chen, BSC
Journal: Diabetes Care
Diabetes Care 2011;34(4):e45
https://doi.org/10.2337/dc11-0143
Published: 21 March 2011
View article titled, Response to Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554
Open the PDF for Response to Comment on: Chen et al. Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack. Diabetes Care 2010;33:2552–2554 in another window
Journal Articles

Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack

Mei Jun Chen, BSC, Ana Jovanovic, MD, Roy Taylor, MD
Journal: Diabetes Care
Diabetes Care 2010;33(12):2552–2554
https://doi.org/10.2337/dc10-0552
Published: 01 December 2010
View article titled, Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack
Open the PDF for Utilizing the Second-Meal Effect in Type 2 Diabetes: Practical Use of a Soya-Yogurt Snack in another window
Journal Articles

The Second-Meal Phenomenon in Type 2 Diabetes

Ana Jovanovic, MD, Jean Gerrard, SRN, Roy Taylor, MD
Journal: Diabetes Care
Diabetes Care 2009;32(7):1199–1201
https://doi.org/10.2337/dc08-2196
Published: 14 April 2009
View article titled, The Second-Meal Phenomenon in Type 2 Diabetes
Open the PDF for The Second-Meal Phenomenon in Type 2 Diabetes in another window
Journal Articles

Increased Daily Walking Improves Lipid Oxidation Without Changes in Mitochondrial Function in Type 2 Diabetes

Michael I. Trenell, PHD, Kieren G. Hollingsworth, PHD, Ee Lin Lim, MRCP, Roy Taylor, MD
Journal: Diabetes Care
Diabetes Care 2008;31(8):1644–1649
https://doi.org/10.2337/dc08-0303
Published: 01 August 2008
View article titled, Increased Daily Walking Improves Lipid Oxidation Without Changes in Mitochondrial Function in Type 2 Diabetes
Open the PDF for Increased Daily Walking Improves Lipid Oxidation Without Changes in Mitochondrial Function in Type 2 Diabetes in another window
Journal Articles

Does Suppression of Postprandial Blood Glucose Excursions by the α-Glucosidase Inhibitor Miglitol Improve Insulin Sensitivity in Diet-Treated Type II Diabetic Patients?

Andrew B Johnson, MD, Roy Taylor, MD
Journal: Diabetes Care
Diabetes Care 1996;19(6):559–563
https://doi.org/10.2337/diacare.19.6.559
Published: 01 June 1996
View article titled, Does Suppression of Postprandial Blood Glucose Excursions by the α-Glucosidase Inhibitor Miglitol Improve Insulin Sensitivity in Diet-Treated Type II Diabetic Patients?
Open the PDF for Does Suppression of Postprandial Blood Glucose Excursions by the α-Glucosidase Inhibitor Miglitol Improve Insulin Sensitivity in Diet-Treated Type II Diabetic Patients? in another window
Journal Articles

Lowering of Plasma Glucose Concentrations With Bezafibrate in Patients With Moderately Controlled NIDDM

Ian R Jones, MD, Andrew Swai, MMed, Roy Taylor, MD, Margaret Miller, SRN, Michael F Laker, MD, K George MM Alberti, DPhil
Journal: Diabetes Care
Diabetes Care 1990;13(8):855–863
https://doi.org/10.2337/diacare.13.8.855
Published: 01 August 1990
View article titled, Lowering of Plasma Glucose Concentrations With Bezafibrate in Patients With Moderately Controlled NIDDM
Open the PDF for Lowering of Plasma Glucose Concentrations With Bezafibrate in Patients With Moderately Controlled NIDDM in another window
Journal Articles

Effects of BAYm 1099, New α-Glucosidase Inhibitor, on Acute Metabolic Responses and Metabolic Control in NIDDM Over 1 Mo

Abu HB Samad, MB, Thomas S Ty Willing, MD, K George MM Alberti, DPhil, Roy Taylor, MD
Journal: Diabetes Care
Diabetes Care 1988;11(4):337–344
https://doi.org/10.2337/diacare.11.4.337
Published: 01 April 1988
View article titled, Effects of BAYm 1099, New α-Glucosidase Inhibitor, on Acute Metabolic Responses and Metabolic Control in NIDDM Over 1 Mo
Open the PDF for Effects of BAYm 1099, New α-Glucosidase Inhibitor, on Acute Metabolic Responses and Metabolic Control in NIDDM Over 1 Mo in another window
Journal Articles

Plasma Free Insulin Profiles After Administration of Insulin by Jet and Conventional Syringe Injection

Roy Taylor, Philip D Home, K George M M Alberti
Journal: Diabetes Care
Diabetes Care 1981;4(3):377–379
https://doi.org/10.2337/diacare.4.3.377
Published: 01 May 1981
View article titled, Plasma Free Insulin Profiles After Administration of Insulin by Jet and Conventional Syringe Injection
Open the PDF for Plasma Free Insulin Profiles After Administration of Insulin by Jet and Conventional Syringe Injection in another window